Network origin in Raymond Andrews first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.
25
| Subsidiary | Pharmaceuticals: Major | 25 |
INVISTA, Inc.
2
| Extinct | Chemicals: Specialty | 2 |
Bristol-Myers Squibb Pharma Co.
2
| Subsidiary | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Raymond Andrews via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Director/Board Member Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Chairman President Chief Tech/Sci/R&D Officer Human Resources Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SMITH & NEPHEW PLC | Medical Specialties | Director/Board Member Director/Board Member | |
| RESVERLOGIX CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| AFFYMAX, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Graduate Degree Graduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel | |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Saskatchewan | College/University | Doctorate Degree | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Private Equity Investor | |
Neurion Pharmaceuticals, Inc.
 Neurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurion Pharmaceuticals, Inc. provides pharmaceutical products. It develops novel molecule drugs for the treatment of central nervous system disorders such as schizophrenia, chronic pain, and Alzheimer's disease. The company was co-founded by Dr. Henry A. Lester, William L. Robbins, and Dr. Dennis A. Dougherty in January, 2002 and is headquartered in Pasadena, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Southern Research Institute
 Southern Research Institute Miscellaneous Commercial ServicesCommercial Services Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The State University of New York | College/University | Doctorate Degree | |
Rittenhouse Ventures LLC
 Rittenhouse Ventures LLC Investment ManagersFinance Rittenhouse Ventures LLC (Rittenhouse Ventures) is a venture capital firm founded in 2006 by Saul Richter and Bruce Luehrs. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Investor | |
| Deltagen Research Laboratories LLC | Corporate Officer/Principal | ||
| Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | ||
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| Perelman School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Oculis SA
 Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
| INOZYME PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Rallybio Holdings LLC
 Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Rallybio Holdings LLC engages in the provision of healthcare services. The company is headquartered in New Haven, CT. | Medical/Nursing Services | Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member | |
Plexium, Inc.
 Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Evommune, Inc.
 Evommune, Inc. Miscellaneous Commercial ServicesCommercial Services Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| BAUSCH + LOMB CORPORATION | Medical Specialties | Director/Board Member Chief Executive Officer President | |
Synnovation Therapeutics, Inc.
 Synnovation Therapeutics, Inc. BiotechnologyHealth Technology Synnovation Therapeutics, Inc. develops novel small molecule targeted therapies for cancer patients. The company is located in the US. | Biotechnology | Director/Board Member Founder | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistics
International
| United States | 41 |
| Canada | 6 |
| United Kingdom | 3 |
| Switzerland | 3 |
| Ireland | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 120 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 40 |
| Chief Tech/Sci/R&D Officer | 30 |
| Chief Executive Officer | 30 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Stein | 34 |
| Joseph Papa | 28 |
| Richard de Schutter | 24 |
| Laurent Fischer | 23 |
| Robert Hopfner | 20 |
| Aamer Khan | 16 |
| Reid Huber | 16 |
| Richard Levy | 16 |
| Christina Ackermann | 15 |
| Steve Friedman | 15 |
| George Farmer | 15 |
| Rebecca Taub | 14 |
| Robert E. Pelzer | 12 |
| Paul S. Anderson | 11 |
| H. Seidel | 11 |
- Stock Market
- Insiders
- Raymond Andrews
- Company connections
